D-1027-2019 Class II Terminated

Recalled by Advanced Pharma Inc. — Houston, TX

FDA drug recall D-1027-2019 was initiated by Advanced Pharma Inc. on Mar 13, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Jan 14, 2020). Affected quantity: 1980 syringes.

Recall details

Product Type
Drugs
Report Date
Mar 27, 2019
Initiation Date
Mar 13, 2019
Termination Date
Jan 14, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1980 syringes

Product description

2% Lidocaine HCl Injectable Solution, 100 mg/5 mL (20 mg per mL), 5mL Sterile single use syringe, NDC: 42852-011-67 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide

Code information

Lot: 10/19/18 1990 01167S Exp. 3/18/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1027-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1027-2019. Report a data issue: hello@regdatalab.com.